Clinical Trials Logo

Clinical Trial Summary

To improve aerobic capacity, muscular function and health-related quality of life in patients with end-stage renal disease (ESRD), regular exercise is recommended. Supervised intradialytic exercise with moderate intensity is an available approach to maintain patients' safety and compliance, and enhance physiological adaptations effectively. The exercise training effects of mitochondrial functions of lymphocyte in ESRD patients, like respiratory capacity, bioenergetic status and thrombosis/immunological regulation remained unclear. Method: ESRD patients (anticipated n=180) would conduct supervised exercise training therapy for 3 days a week for 6 months in the hospital and 3 months at home. Cardiopulmonary exercise therapy would be performed before and after the intervention. A high resolution respirometer and a flow cytometer are used to determine the oxygen consumption rate/mitochondrial respiration in mitochondria and subtypes of lymphocyte, respectively.


Clinical Trial Description

Renal dysfunction results from cardiovascular-related comorbidities or metabolic disorders, accumulating excessive inflammatory products or damage mitochondrial bioenergetics health in platelet and lymphocyte, then lead to chronic kidney disease (CKD) eventually. End-stage renal disease (ESRD) is the highest level of CKD, patients at ESRD stage suffer from severe uremia and renal failure, preparing renal replacement therapy: dialysis. Hemodialysis (HD) are the most common treatment for ESRD patients, especially in Taiwan, where reports the highest prevalence of HD globally due to related chronic diseases and comprehensive National Health Insurance program. Maintenance (long-term) HD results in physical inactivity and low quality of life; thus, exercise training is recommended to improve physiological adaptations and functional capacity for HD patients. With supervised condition and a safer progression, intradialytic exercise in clinical settings provides low dropout rate and superior compliance. Mitochondrial dysfunction is one of the concerned issues in ESRD, impaired mitochondria also dysregulate circulating lymphocyte, leading to immunological senescence . The purposes of the present study are to establish the measurements of mitochondrial functions of platelet and lymphocyte in HD patients, and determine cardiovascular and muscular fitness along with the effects of intradialytic exercise. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06417307
Study type Interventional
Source Chang Gung Memorial Hospital
Contact Jong-Shyan Wang, PhD
Phone +886-3-2118800
Email s5492@mail.cgu.edu.tw
Status Recruiting
Phase N/A
Start date August 1, 2021
Completion date July 31, 2024

See also
  Status Clinical Trial Phase
Completed NCT05980845 - The Effect Nature Sounds and Music on Hemodialysis Patients N/A
Recruiting NCT05020717 - Retrospective Survey of Hyperkalemia in Hemodialysis
Recruiting NCT04046042 - Virtual Reality Intradialysis: Last vs. First Part of the Session N/A
Recruiting NCT04094038 - The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Quality of Life in Hemodialysis Patients Phase 4
Completed NCT03311581 - The Feasibility of Propofol TCI in Hemodialysis Patients Undergoing Arteriovenous Shunt Surgery Phase 1
Completed NCT05531175 - REIKI APPLICATION PAIN, FATIGUE AND ITCHING IN HEMODIALYSIS PATIENTS N/A
Completed NCT04057313 - Coffee in Hemodialysis and Headache N/A
Completed NCT03061552 - Inferior Vena Cava Sonography in Hemodialysis Patients and Quality of Life N/A
Completed NCT03251573 - The Cohort Study of Cognitive Impairment in Chinese Hemodialysis Patients
Completed NCT05568342 - The Effect of Roy Adaptation-Based Nursing Intervention N/A
Completed NCT03527680 - Effect of Lactobacillus Rhamnosus on Serum Uremic Toxins in Hemodialysis N/A
Completed NCT04063423 - Non- Clinical Coagulation Activation During Hemodialysis
Active, not recruiting NCT06203795 - Dialysis Performance of the FX CorAL Membrane N/A
Completed NCT04319328 - Is Cefazolin, Ceftazidime and Ciprofloxacin Dosing Optimal in Hemodialysis Patients?
Completed NCT03627884 - Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation Phase 4
Completed NCT05132036 - Lung Ultrasound Assessment of Fluid Overload in Haemodialysis Patients N/A
Completed NCT03076528 - An Innovative Virtually Supervised Exercise for Dialysis Patients Phase 2
Completed NCT06098443 - Acupressure Versus Transcutaneous Electrical Nerve Stimulation on Pain and Quality of Life Intradialysis N/A
Completed NCT04645121 - Carbon Monoxide-based Rebreathing Method and Bioimpedance in Hemodialysis Patients
Recruiting NCT04127877 - Bio Impedance-assisted Monitoring of Chronic Hemodialysis Patients N/A